A Beginner's Guide to Healing and Growing with Psychedelics. With Matt Zemon

Therapy Innovations

Psychedelics are revolutionizing mental health treatment, offering promising alternatives to traditional therapies. Matt Zemon highlights the work of MAPS and their groundbreaking research on MDMA for treatment-resistant PTSD. This approach, which involves only a few sessions, has shown that 67% of participants no longer qualify as having PTSD after treatment, a significant breakthrough in mental health care 1.

It's such a large number, it's almost unbelievable. Makes you want to go like, well, that doesn't sound right. Let me check that out. Check it out. It's 67%.

--- Matt Zemon

Zemon also discusses the potential of ketamine, which is legal across the U.S., as a viable treatment option with fewer side effects than traditional antidepressants 2.

   

Access Challenges

Despite the promising results, accessibility and affordability remain significant barriers to psychedelic-assisted therapies. Matt Zemon shares his personal motivation to address these challenges, inspired by a family member's mental health crisis and the systemic dysfunction he witnessed 2. He emphasizes the high cost of treatments like ketamine, which can range from $4,500 to $6,000 for six sessions and are often not covered by insurance.

I am hyper focused on how can I help with this unhappiness epidemic. How can I help solve some of these massive mental health challenges?

--- Matt Zemon

To combat these issues, Zemon is working on telehealth solutions to reduce costs and increase accessibility, aiming to replicate the in-clinic experience at home 2.